A special thanks to Sanofi for its support to the COVHEMATO projectLearn more
SiRIC Curamus presentationLearn more
Support the CuramusLearn more
Our ambition is to accelerate research on cancers that are particularly difficult to treat through the development of diagnostic and therapeutic innovations to benefit patients as quickly as possible and thus improve their care and follow-up. We are counting on your support.
Director of Curamus
Cancer United Research Associating Medicine, University & Society
Curamus is one of the eight integrated cancer research sites (SiRIC), certified by the National Cancer Institute (INCa), the Ministry of Solidarity and Health, Inserm and ITMO Cancer AVIESAN (National Alliance for Life Sciences and Health). The SIRIC Curamus aims to bring together and promote the synergy of its multidisciplinary teams around the AP-HP.SORBONNE UNIVERSITY hospital-university group in order to accelerate research and innovation in cancerology to improve care for the benefit of patients.
Curamus is supported by the AP-HP.Sorbonne University Hospital Group and by the 3 faculties of Medicine, Engineering Sciences and Literature of the Sorbonne University under the federation of the University Institute of Cancerology (IUC), in association with their institutional partners, Inserm and CNRS.
Follow the activity of CURAMUS
Stay informed about translational and clinical research in SiRIC CURAMUS
🎙La Minute Santé: interview of Pr Véronique Leblond
Watch the interview of Pr Véronique Leblond on chronic lymphocytic leukemia for “La Minute Santé” proposed by l’Observatoire de la […]
CANCERVIH network: webinar the 6th of november 2020
For the third national day of CANCERVIH network, organization dedicated to patients with cancer and infected by the human immunodeficiency […]